QuadMedicine Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Cash & Equivalents	2,821	10,263	4,449
Cash & Short-Term Investments	4,251	10,263	4,449
Cash Growth	-0.29%	130.69%	-
Accounts Receivable	1,401	1,100	18.41
Other Receivables	143.18	3.22	0.23
Receivables	1,544	1,103	18.64
Prepaid Expenses	34.85	86.89	512.18
Other Current Assets	499.57	232.97	69.03
Total Current Assets	6,330	11,686	5,049
Property, Plant & Equipment	19,338	19,752	19,549
Long-Term Investments	-	10	-
Other Intangible Assets	483.35	493.21	364.21
Long-Term Accounts Receivable	0	-0	-0
Other Long-Term Assets	204.72	157.35	257.19
Total Assets	26,356	32,098	25,219
Short-Term Debt	500	500	-
Current Portion of Long-Term Debt	99.6	99.6	-
Current Portion of Leases	234.13	206.35	295.71
Other Current Liabilities	3,465	5,524	3,616
Total Current Liabilities	4,299	6,330	3,912
Long-Term Debt	6,376	6,451	5,800
Long-Term Leases	139.87	106.84	327.7
Other Long-Term Liabilities	9,134	7,611	6,217
Total Liabilities	19,949	20,498	16,256
Common Stock	4,795	4,676	4,358
Additional Paid-In Capital	48,010	45,483	38,472
Retained Earnings	-48,115	-41,688	-36,720
Comprehensive Income & Other	1,717	3,128	2,853
Shareholders' Equity	6,407	11,600	8,963
Total Liabilities & Equity	26,356	32,098	25,219
Total Debt	7,350	7,363	6,423
Net Cash (Debt)	-3,098	2,899	-1,975
Net Cash Per Share	-334.73	332.59	-228.65
Filing Date Shares Outstanding	9.59	9.35	8.74
Total Common Shares Outstanding	9.59	9.35	8.74
Working Capital	2,031	5,356	1,137
Book Value Per Share	668.08	1240.40	1025.97
Tangible Book Value	5,924	11,107	8,599
Tangible Book Value Per Share	617.68	1187.66	984.28
Land	2,187	2,187	1,951
Buildings	9,683	9,683	8,572
Machinery	10,688	9,130	7,681
Construction In Progress	142.6	171.69	555.41

Source: S&P Global Market Intelligence. Standard template. Financial Sources.